Hepatic scan defects following radiotherapy for lymphoma

Area of Science:

• Hepatology
• Radiology
• Oncology

Background:

• Liver involvement is common in lymphoma patients.
• Radiotherapy is a standard treatment for lymphoma, often involving the liver.
• Hepatic scan findings require careful interpretation to distinguish treatment effects from disease progression.

Purpose of the Study:

• To characterize hepatic scan defects following liver radiotherapy in lymphoma patients.
• To differentiate radiation-induced defects from other causes.
• To assess the temporal course and persistence of these defects.

Main Methods:

• Retrospective analysis of 21 lymphoma patients treated with radiotherapy.
• Evaluation of hepatic scans for specific defect patterns.
• Correlation of scan findings with radiotherapy fields and follow-up duration.

Main Results:

• Two patterns identified: Type I (radiation port defect) and Type II (left lobe attenuation).
• Type I defects were seen in 5/7 patients within six weeks post-radiotherapy.
• Type II defects developed in all 7 early-evaluated patients and 17/21 overall, persisting up to 66 months.

Conclusions:

• Characteristic hepatic scan defects occur frequently after liver radiotherapy in lymphoma.
• Type II defects are common, persistent findings that should not be mistaken for disease.
• Awareness of these specific patterns aids accurate patient evaluation.